EORTC at ISOQOL Annual Conference: President’s Award and 12 EORTC abstracts
23 Oct 2018
The International Society for Quality of Life Research (ISOQOL) is an international academic society, which aims to advance the study of health-related quality of life and other patient-reported outcomes. ISOQOL will be holding its 25th Annual Conference in Dublin Ireland from October 24 to 27, 2018. Members of the EORTC QLG will be presenting a total of 12 abstracts for this year’s conference. We would also like to congratulate Dr. Andrew Bottomley for being the recipient of this year’s President’s Award for his work in advancing HRQOL research and his outstanding contributions to the Society.
Symposium
- Setting Standards for Analysis of Patient Reported Outcomes and Quality of Life Data for International Cancer Clinical Trials (SISAQOL consortium): Progress update
Presentation Number: Individual presentation in the “Minimizing Research Waste and Maximising the Impact of Patient Reported Outcome Trial Results” Symposium
Speaker: Andrew Bottomley (Belgium)
Date: 26.10.2018 – Lecture Time: 11:15 – Location: Pembroke & Herbert, Ground Floor
Oral Presentations
- Evidence-based approach to determine meaningful change in scores of the EORTC QLQ-C30 in breast and head and neck cancer: on behalf of the EORTC Breast, Head and Neck and Quality of Life Groups
Presentation Number: 101.4
Speaker: Jammbe Z Musoro (Belgium)
Date: 25.10.2018 – Lecture Time: 2:44pm – Location: Meeting Room 1 + 2
- Establishing the European Norm for the health-related quality of life scales of the EORTC Computer-Adaptive Test and new reference values for the QLQ-C30 based on a population survey of 15,386 persons across 13 European countries, the USA, and Canada
Presentation Number: 106.4
Speaker: Sandra Nolte (Germany)
Date: 25.10.2018 – Lecture Time: 5:04pm – Location: Pembroke & Herbert, Ground Floor
- Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative
Presentation Number: 203.4
Speaker: Madeline Pe* (Belgium)
Date: 26.10.2018 – Lecture Time: 2:59pm – Location: Pembroke & Herbert, Ground Floor
*New investigator oral presentation finalist
- Phase I and II development of an EORTC QOL cancer survivorship assessment strategy: issue generation and construction of provisional questionnaires
Presentation Number: 301.1
Speaker: Marieke van Leeuwen (The Netherlands)
Date: 27.10.2018 – Lecture Time: 3:55pm – Location: Meeting Room 1 + 2, Second Floor
- Qualitative evidence on the content validity of EORTC QLQ-C30: Initial findings
Presentation Number: 304.2
Speaker: Kim Cocks (UK)
Date: 27.10.2018 – Lecture Time: 4:13pm – Location: Pembroke & Herbert, Ground Floor
Poster Presentations
- Quality of life as an outcome in EORTC clinical trials: 15 years of clinical trial research
Poster Number: 1004
Poster Presenter: Irina Ghislain* (Belgium)
Date: 25.10.2018 – Lecture Time: 3:25pm – Location: Lansdowne Room, Ground Floor
*Outstanding poster award finalist
- Organizing the EORTC Item Library: A Mixed Methods: Exploratory Content Analysis
Poster Number: 2025
Poster Presenter: Claire Piccinin (Belgium)
Date: 26.10.2018 – Lecture Time: 10:35am – Location: Lansdowne Room, Ground Floor
- Translations of item lists created with the EORTC Item Library: updated translation and review procedure
Poster Number: 2029
Poster Presenter: Dagmara Kulis (Belgium)
Date: 26.10.2018 – Lecture Time: 10:35am – Location: Lansdowne Room, Ground Floor
- International validation of the EORTC QLQ-CAT
Poster Number: 2033
Poster Presenter: Morten Petersen (Denmark)
Date: 26.10.2018 – Lecture Time: 10:35am – Location: Lansdowne Room, Ground Floor
- Development of thresholds for clinical importance for the EORTC QLQ-C30 and the computer-adaptive EORTC measures
Poster Number: 3043
Poster Presenter: Fanny Loth (Austria)
Date: 27.10.2018 – Lecture Time: 9:45am – Location: Lansdowne Room, Ground Floor
- Reference Values for EORTC QLQ-C30 in Early and Metastatic Breast Cancer
Poster Number: 3047
Poster Presenter: Justyna Mierzynska (Belgium)
Date: 27.10.2018 – Lecture Time: 9:45am – Location: Lansdowne Room, Ground Floor
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023